Engineered Microbes for Producing Anticholinergics

被引:1
作者
Courdavault, Vincent [1 ]
Cassereau, Julien [2 ]
Papon, Nicolas [3 ,4 ]
机构
[1] Univ Tours, Fac Pharm, EA2106 BBV, 31 Ave Monge, F-37200 Tours, France
[2] Univ Angers, MitoVasc Inst, INSERM 1083, MitoLab,CNRS,UMR 6015, Angers, France
[3] Univ Brest, Univ Angers, Host Pathogen Interact Study Grp GEIHP, EA 3142, Angers, France
[4] Univ Angers, Federat Struct Res Cellular Interact & Therapeut, SFR 4208 ICAT, Angers, France
关键词
anticholinergics; bioproduction; hyoscyamine dehydrogenase; tropane alkaloids; yeast;
D O I
10.1002/cbic.202000757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tropane alkaloids (TAs) hyoscyamine and scopolamine function as acetylcholine receptor antagonists and are used clinically as parasympatholytics to treat neuromuscular disorders in humans. While TAs are synthesized in a small subset of plant families, these specialized metabolites are only accumulated in limited quantities in plant organs. The complex chemical structures of these compounds make their industrial production by chemical synthesis very challenging, Therefore, the supply of these TAs still relies on intensive farming of Duboisia shrubs in tropical countries. Many adverse factors such as climate fluctuations and pandemics can thus influence annual world production. Based on the landmark microbial production of the antimalarial semi-synthetic artemisinin, the Smolke group recently developed a yeast cell factory capable of de novo synthesizing hyoscyamine and scopolamine, thus paving the way for an alternative production of these compounds.
引用
收藏
页码:1368 / 1370
页数:3
相关论文
共 50 条
  • [1] Poly(alkyl glycidyl ether) hydrogels for harnessing the bioactivity of engineered microbes
    Johnston, Trevor G.
    Fellin, Christopher R.
    Carignano, Alberto
    Nelson, Alshakim
    FARADAY DISCUSSIONS, 2019, 219 : 58 - 72
  • [2] SOFT ANTICHOLINERGICS
    HAMMER, RH
    KUMAR, GN
    ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (2-3) : 281 - 292
  • [3] Engineered Stochastic Adhesion Between Microbes as a Protection Mechanism Against Environmental Stress
    Lewis, Daniel D.
    Vanella, Rosario
    Vo, Christopher
    Rose, Lesilee
    Nash, Michael
    Tan, Cheemeng
    CELLULAR AND MOLECULAR BIOENGINEERING, 2018, 11 (05) : 367 - 382
  • [4] Anticholinergics for Treatment of Asthma
    Quirce, S.
    Dominguez-Ortega, J.
    Barranco, P.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2015, 25 (02) : 84 - 93
  • [5] The use of anticholinergics in asthma
    Beakes, DE
    JOURNAL OF ASTHMA, 1997, 34 (05) : 357 - 368
  • [6] Anticholinergics for urge incontinence
    Mappilakkandy, R.
    Mistri, A. K.
    REVIEWS IN CLINICAL GERONTOLOGY, 2010, 20 (01) : 30 - 41
  • [7] Fast-Growing Engineered Microbes: New Concerns for Gain-of-Function Research?
    Pei, Lei
    Schmidt, Markus
    FRONTIERS IN GENETICS, 2018, 9
  • [8] Anticholinergics/Antimuscarinic Drugs in Asthma
    Xavier Soler
    Joe Ramsdell
    Current Allergy and Asthma Reports, 2014, 14
  • [9] Anticholinergics/Antimuscarinic Drugs in Asthma
    Soler, Xavier
    Ramsdell, Joe
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (12) : 1 - 9
  • [10] Advances in engineered microbes for sustainable biofuel production: Current research and future outlook on lignocellulose utilization
    Kamalesh, R.
    Shaji, Alan
    Saravanan, A.
    Vickram, A. S.
    Yaashikaa, P. R.
    INDUSTRIAL CROPS AND PRODUCTS, 2024, 222